Tissue factor-enriched vesicles are taken up by platelets and induce platelet aggregation in the presence of factor VIIa

Irene Lopez-Vilchez; Gines Escolar; Maribel Diaz-Ricart; Berta Fuste; Ana M. Galan; James G. White

doi:10.1160/TH06-04-0216

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2007; 97(02): 202-211
DOI: 10.1160/TH06-04-0216

Platelets and Blood Cells

Schattauer GmbH

Tissue factor-enriched vesicles are taken up by platelets and induce platelet aggregation in the presence of factor VIIa

Authors

Irene Lopez-Vilchez

¹Servicio de Hemoterapia y Hemostasia, Hospital Clinic, Centre de Diagnostic Biomedic, IDIBAPS, Universidad de Barcelona, Spain;
Gines Escolar

¹Servicio de Hemoterapia y Hemostasia, Hospital Clinic, Centre de Diagnostic Biomedic, IDIBAPS, Universidad de Barcelona, Spain;
Maribel Diaz-Ricart

¹Servicio de Hemoterapia y Hemostasia, Hospital Clinic, Centre de Diagnostic Biomedic, IDIBAPS, Universidad de Barcelona, Spain;
Berta Fuste

¹Servicio de Hemoterapia y Hemostasia, Hospital Clinic, Centre de Diagnostic Biomedic, IDIBAPS, Universidad de Barcelona, Spain;
Ana M. Galan

¹Servicio de Hemoterapia y Hemostasia, Hospital Clinic, Centre de Diagnostic Biomedic, IDIBAPS, Universidad de Barcelona, Spain;
James G. White

²Department of Laboratory and Clinical Medicine and Pediatrics, University of Minnesota, Minneapolis, Minnesota, USA

Abstract

Summary

We investigated the interactions of vesicles containing human tissue factor (TF) with platelets and evaluated responses induced by rFVIIa using standard aggregometry, ultrastructural and flow-cytometry techniques. Washed platelets were exposed to a preparation of placental human TF (pTF) or to a relipidated formulation of recombinant humanTF (rTF). Under stirring conditions, pTF induced reversible aggregation with platelets returning to their resting state after 5 minutes. This reversible response to pTF was partially inhibited by antibodies against CD62-P, but not by antithrombin agents, and was not observed with rTF. Sequential ultrastructural studies revealed uptake of both TF preparations by platelets involving traffic of vesicles through channels of the open canalicular system (OCS). Immunocytochemical studies on cryosections identified TF in the OCS, and occasionally in the alpha-granules of the platelets. These processes were faster with pTF than with rTF, but bothTF preparations accumulated in platelets at the end of incubation periods. Flow cytometry studies revealed the presence of other cellular antigens (CD62-P, CD14 and CD45) associated to the pTF. Addition of rFVIIa to washed platelets exposed to pTF or rTF, caused a thrombin dependent irreversible platelet aggregation. Our studies demonstrate that platelets possess mechanisms to capture and incorporate TF-rich vesicles. These processes are accelerated by the presence of other cellular antigens in the vesicles. Our findings may explain the hemostatic action of rFVIIa in severely hemodiluted patients, but are also relevant for the understanding of potential implications of TF-associated to platelets in the propagation of thrombus.

Keywords

Platelets - tissue factor - vesicles - traffic - rFVIIa

Full Text

References

References
1 Sakariassen KS, Bolhuis PA, Sixma JJ. Human blood platelet adhesion to artery subendothelium is mediated by factor VIII-Von Willebrand factor bound to the subendothelium. Nature 1979; 279: 636-638.
2 Savage B, Saldivar E, Ruggeri ZM. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 1996; 84: 289-297.
3 Sakariassen KS, Nievelstein PF, Coller BS. et al. The role of platelet membrane glycoproteins Ib and IIb- IIIa in platelet adherence to human artery subendothelium. Br J Haematol 1986; 63: 681-691.
4 Turitto VT, Hall CL. Mechanical factors affecting hemostasis and thrombosis. Thromb Res 1998; 92: S25-31.
5 Wu YP, de Groot PG, Sixma JJ. Shear stress-induced detachment of blood platelets from various surfaces. Arterios Thromb Vasc Biol 1997; 17: 3202-3.
6 Hathcock JJ, Nemerson Y. Platelet deposition inhibits tissue factor activity: in vitro clots are impermeable to factor Xa. Blood 2004; 104: 123-127.
7 Giesen PLA, Rauch U, Bohrmann B. et al. Bloodborne tissue factor: Another view of thrombosis. Proc Natl Acad Sci USA 1999; 96: 2311-2315.
8 Butenas S, Bouchard BA, Brummel-Ziedins KE. et al. Tissue factor activity in whole blood. Blood 2005; 105: 2764-2770.
9 Zillmann A, Luther T, Muller I. et al. Platelet-associated tissue factor contributes to the collagen-triggered activation of blood coagulation. Biochem Biophys Res Commun 2001; 281: 603-609.
10 Perez-Pujol S, Aras O, Lozano M. et al. Stored platelets contain residual amounts of tissue factor: evidence from studies on platelet concentrates stored for prolonged periods. Transfusion 2005; 45: 572-579.
11 Muller I, Klocke A, Alex M. et al. Intravascular tissue factor initiates coagulation via circulating microvesicles and platelets. FASEB J 2003; 17: 476-478.
12 Falati S, Liu QD, Gross P. et al. Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J Exp Med 2003; 197: 1585-1598.
13 Aras O, Shet A, Bach RR. et al. Induction of microparticle- and cell-associated intravascular tissue factor in human endotoxemia. Blood 2004; 103: 4545-4553.
14 Shet AS, Aras O, Gupta K. et al. Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes. Blood 2003; 102: 2678-2683.
15 Orvim U, Roald HE, Stephens RW. et al. Tissue factor- induced coagulation triggers platelet thrombus formation as efficiently as fibrillar collagen at arterial blood flow conditions. Arterios Thromb 1994; 14: 1976-1983.
16 Smith SA, Comp PC, Morrissey JH. Phospholipid composition controls thromboplastin sensitivity to individual clotting factors. J Thromb Haemost 2006; 4: 820-827.
17 Bader R, Mannucci PM, Tripodi A. et al. Multicentric evaluation of a new PT reagent based on recombinant human tissue factor and synthetic phospholipids. Thromb Haemost 1994; 71: 292-299.
18 White JG. The morphology of platelet function. Meth Hematol 1983; 4: 1-25.
19 Escolar G, Monteagudo J, Villamor N. et al. Ristocetin induces platelet aggregation: a morphological demonstration. Br J Haematol 1988; 69: 379-386.
20 Tokuyasu KT. Use of poly(vinylpyrrolidone) and poly(vinyl alcohol) for cryoultramicrotomy. Histochem J 1989; 21: 163-171.
21 Griffiths G, McDowall A, Back R. et al. On the preparation of cryosections for immunocytochemistry. J Ultrastruct Res 1984; 89: 65-78.
22 Webster P, Grab DJ. Intracellular colocalization of variant surface glycoprotein and transferrin-gold in Trypanosoma brucei. J Cell Biol 1988; 106: 279-288.
23 Lozano M, Estebanell E, Cid J. et al. Platelet concentrates prepared and stored under currently optimal conditions: minor impact on platelet adhesive and cohesive functions after storage. Transfusion 1999; 39: 951-959.
24 Weiss HJ, Turitto VT, Baumgartner HR. et al. Evidence for the presence of tissue factor activity on subendothelium. Blood 1989; 73: 968-975.
25 Balasubramanian V, Grabowski E, Bini A. et al. Platelets, circulating tissue factor, and fibrin colocalize in ex vivo thrombi: real-time fluorescence images of thrombus formation and propagation under defined flow conditions. Blood 2002; 100: 2787-2792.
26 Del Conde I, Shrimpton CN, Thiagarajan P. et al. Tissue factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood 2005; 106: 1604-1611.
27 White JG, Escolar G. The blood platelet open canalicular system – a two-way street. Eur J Cell Biol 1991; 56: 233-242.
28 White JG, Clawson CC. Effects of small latex particle uptake on the surface connected canalicular system of blood platelets: a freeze-fracture and cytochemical study. Diagn Histopathol 1982; 5: 3-10.
29 Behnke O. Surface membrane clearing of receptor ligand complexes in human blood platelets. J Cell Sci 1987; 87: 465-472.
30 Youssefian T, Drouin A, Masse JM. et al. Host defense role of platelets: engulfment of HIV and Staphylococcus aureus occurs in a specific subcellular compartment and is enhanced by platelet activation. Blood 2002; 99: 4021-4029.
31 White JG. Platelets are covercytes, not phagocytes: uptake of bacteria involves channels of the open canalicular system. Platelets 2005; 16: 121-131.
32 White JG. Functional significance of mobile receptors on human platelets. Arterios Thromb 1993; 13: 1236-1243.
33 Rauch U, Bonderman D, Bohrmann B. et al. Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor. Blood 2000; 96: 170-175.
34 Falati S, Gross PL, Merrill-Skoloff G. et al. In vivo models of platelet function and thrombosis: study of real-time thrombus formation. Methods Mol Biol 2004; 272: 187-197.
35 Mallat Z, Benamer H, Hugel B. et al. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 2000; 101: 841-843.
36 Lopez JA, Kearon C, Lee AYY. Deep venous thrombosis. Hematology 2004; 2004: 439-456.
37 Hagberg IA, Roald HE, Lyberg T. Adhesion of leukocytes to growing arterial thrombi. Thromb Haemost 1998; 80: 852-858.
38 Montrucchio G, Bosco O, Del Sorbo L. et al. Mechanisms of the priming effect of low doses of lipopolysaccharides on leukocyte-dependent platelet aggregation in whole blood. Thromb Haemost 2003; 90: 872-881.
39 Hedner U. NovoSeven (R) as a universal haemostatic agent. Blood Coag Fibrinolysis 2000; 11: S107-11.
40 O'Connell NM, Perry DJ, Hodgson AJ. et al. Recombinant FVIIa in the management of uncontrolled hemorrhage. Transfusion 2003; 43: 1711-1716.
41 Rauch U, Nemerson Y. Circulating tissue factor and thrombosis. Curr Opin Hematol 2000; 7: 273-277.
42 Bogdanov VY, Balasubramanian V, Hathcock J. et al. Alternatively spliced human tissue factor: a circulating soluble, thrombogenic protein. Nature 2003; 9: 458-462.